The latest closing stock price for Alnylam Pharmaceuticals as of May 30, 2025 is 304.56.
An investor who bought $1,000 worth of Alnylam Pharmaceuticals stock at the IPO in 2004 would have $49,676 today, roughly 50 times their original investment - a 20.55% compound annual growth rate over 21 years.
The all-time high Alnylam Pharmaceuticals stock closing price was 304.56 on May 30, 2025.
The Alnylam Pharmaceuticals 52-week high stock price is 306.00, which is 0.5% above the current share price.
The Alnylam Pharmaceuticals 52-week low stock price is 147.25, which is 51.7% below the current share price.
The average Alnylam Pharmaceuticals stock price for the last 52 weeks is 254.38.
An investor who bought $1,000 worth of Alnylam Pharmaceuticals stock at the IPO in 2004 would have $49,676 today, roughly 50 times their original investment - a 20.55% compound annual growth rate over 21 years.
The all-time high Alnylam Pharmaceuticals stock closing price was 304.56 on May 30, 2025.
The Alnylam Pharmaceuticals 52-week high stock price is 306.00, which is 0.5% above the current share price.
The Alnylam Pharmaceuticals 52-week low stock price is 147.25, which is 51.7% below the current share price.
The average Alnylam Pharmaceuticals stock price for the last 52 weeks is 254.38.